Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.09.19 | Ragnarok M: Veröffentlichung von Eternal Love für die europäischen Nutzer am 16. Oktober | 489 | Business Wire | - Die veröffentlichte Version ist für die Regionen EU, Türkei und Russland bestimmt, sodass das Spiel nunmehr nahezu weltweit verfügbar ist. - Die EU-Version von Ragnarok M: Eternal Love wird... ► Artikel lesen | |
27.09.19 | Natuzzi Announces Consolidated Results for the Second Quarter and First Six Months Of 2019 | 632 | Business Wire | Direct Retail Operations (DOS) Improving Revenues and Profitability; Wholesale Still Suffering From US Tariffs With a Penalized Profitability; The Company Is Exploring Outsourced... ► Artikel lesen | |
27.09.19 | Pershing Square Holdings, Ltd. Announces Transactions in Own Shares | 503 | Business Wire | Regulatory News:
Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (NA:PSH) ("PSH") today announced that it has purchased, through PSH's agent, Jefferies International Limited ("Jefferies")... ► Artikel lesen | |
27.09.19 | Aktualisierte Ergebnisse der SPARTAN-Studie zeigen Reduzierung des Mortalitätsrisikos um 25 Prozent durch die Behandlung von Patienten mit nicht metastasiertem, kastrationsresistentem Prostatakarzinom (nmCRPC) mit ERLEADA (Apalutamid) | 352 | Business Wire | Ergebnisse der zweiten Zwischenanalyse der Phase-3-Studie SPARTAN in einer mündlichen Präsentation auf der ESMO 2019 vorgestellt, gleichzeitige Veröffentlichtung in der Annals of Oncology
Die... ► Artikel lesen | |
27.09.19 | PROTECT-III-Ergebnisse auf der TCT 2019 präsentiert - klinische Daten zeigen Outcome-Verbesserungen bei geschützter PCI mit Impella | 378 | Business Wire | Abiomed (NASDAQ: ABMD) gibt die Ergebnisse der Studie PROTECT III bekannt. Die laufende, prospektive, einarmige, nach FDA-Zulassung eingeleitete Studie dient der Unterstützung der PMA-Zulassung... ► Artikel lesen | |
27.09.19 | AM Best Affirms Credit Ratings of R.V.I. Guaranty Co., Ltd. and R.V.I. America Insurance Company | 317 | Business Wire | AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of "a-" ofR.V.I. Guaranty Co., Ltd. (RVI Guaranty) (Bermuda) and its subsidiary, R.V.I.... ► Artikel lesen | |
27.09.19 | Safe Orthopaedics announces its results for the first half of 2019 | 553 | Business Wire | Sales growth in the first half of 2019: +23% Major commercial investment Strengthening of the financial visibility through to 2022 Recruitment of additional Strategy, Sales... ► Artikel lesen | |
27.09.19 | LivaNova Enrolls First Patient in RECOVER Clinical Study | 504 | Business Wire | LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced the first patient enrolled in "A Prospective, Multi-center, Randomized Controlled Blinded Trial... ► Artikel lesen | |
27.09.19 | FDA Approves Genentech's Rituxan (rituximab) in Children With Two Rare Blood Vessel Disorders | 509 | Business Wire | -Rituxan is the first and only FDA-approved treatment for pediatric patients 2 years of age and older living with granulomatosis with polyangiitis or microscopic polyangiitis- -These two forms... ► Artikel lesen | |
27.09.19 | Morgan Stanley & Co. International plc - Half-yearly Financial Report - 30 June 2019 | 544 | Business Wire | Regulatory News:
Pursuant to the rules of NASDAQ OMX and the Nordic Growth Market (NGM), we hereby give notice that Morgan Stanley Co. International plc, an issuer of securities listed on NASDAQ... ► Artikel lesen | |
27.09.19 | Incyte meldet positive aktualisierte Ergebnisse der Phase-2-Studie zu Pemigatinib bei Patienten mit bereits behandeltem, fortgeschrittenem Cholangiokarzinom | 1.933 | Business Wire | Die auf der ESMO präsentierten Daten unterstützen die geplante Einreichung eines neuen Zulassungsantrags (NDA) für Pemigatinib bei der U.S. Food and Drug Administration (FDA) vor Ende 2019 ... ► Artikel lesen | |
27.09.19 | Powder Coatings Markets in the United States & Europe, 2019-2026 - A $4.29 Billion Industry Opportunity by 2026 - ResearchAndMarkets.com | 324 | Business Wire | The "U.S. Europe Powder Coatings Market: Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.
According to the report, the U.S.... ► Artikel lesen | |
27.09.19 | SpendEdge's Latest Blog Discusses the Procurement Scenario of the Global Industrial Sector against the Backdrop of a High Crude Oil Market Price | Oil Price Forecasts | 425 | Business Wire | SpendEdge, a leading procurement market intelligence company, has announced the completion of its article that underlines the impact of the price rise in the crude oil market on some of the critical... ► Artikel lesen | |
27.09.19 | Global Patient Lifting Devices Market 2019-2023 | 8% CAGR Projection Over the Next Five Years | Technavio | 254 | Business Wire | The patient lifting devices market is expected to post a CAGR close to 8% during the period 2019-2023, according to the latest market research report by Technavio. Request a free sample reportThis... ► Artikel lesen | |
27.09.19 | How Sales Force Effectiveness is Reinventing the Pharma Landscape in the US | A FREE Resource by Quantzig | 246 | Business Wire | Quantzig, a leading analytics advisory firm that delivers customized analytics solutions, has announced the completion of its free resource that highlights how sales force effectiveness is reinventing... ► Artikel lesen | |
27.09.19 | Rice Market - Procurement Intelligence Report, Rice Price, Rice Strategic Sourcing Insights Now Available from SpendEdge | 235 | Business Wire | SpendEdge, a global procurement market intelligence firm, has announced the release of its Global Rice Market Procurement Intelligence Report.This press release features multimedia. View the full... ► Artikel lesen | |
27.09.19 | Advicenne Publishes its 2019 Half-Year Financial Report | 395 | Business Wire | Regulatory News:
Advicenne (Paris:ADVIC) (BSE:ADVIC) (Euronext: ADVIC FR0013296746), a specialty pharmaceutical company focused on the development and commercialization of therapeutic products... ► Artikel lesen | |
27.09.19 | Ontex: Transparency Declaration Notification | 366 | Business Wire | Disclosure made according to the requirements of Article 14 of the law of 2 May 2007
Regulatory News:
Ontex Group NV ("Ontex") (Paris:ONTEX) discloses the notification of significant shareholdings... ► Artikel lesen | |
27.09.19 | Jacquet Metal Service SA: Statement in Compliance With the Article 223-16 of the General Regulation of the Financial Markets Authority (AMF - Autorité des Marchés Financiers) | 441 | Business Wire | Regulatory News: Jacquet Metal Service SA (Paris:JCQ): Date Total number of shares Number of voting rights
exercisable at
Shareholders' meeting
August... ► Artikel lesen | |
27.09.19 | One Day Financial Evolution Seminar: AI, Machine Learning & Sentiment Analysis (Opfikon-Glattbrugg, Switzerland - October 29, 2019) - ResearchAndMarkets.com | 232 | Business Wire | The "Financial Evolution: AI, Machine Learning Sentiment Analysis" conference has been added to ResearchAndMarkets.com's offering.
Artificial Intelligence and Machine Learning (AI ML) and Sentiment... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 13.154 |
TESLA | 4.887 |
DEUTSCHE BANK | 3.895 |
NVIDIA | 3.584 |
META PLATFORMS | 3.488 |
TUI | 2.834 |
AIXTRON SE | 2.362 |
SUPER MICRO COMPUTER | 2.328 |
NEL | 2.298 |
BAYER | 2.109 |
RHEINMETALL | 2.093 |
VARTA | 2.045 |
BASF | 2.024 |
INFINEON | 1.675 |
RENK GROUP | 1.609 |
BYD | 1.445 |
COMMERZBANK | 1.388 |
PLUG POWER | 1.363 |
HELLOFRESH | 1.068 |
RWE | 1.043 |
DEUTSCHE LUFTHANSA | 1.040 |
THYSSENKRUPP | 1.021 |
ALLIANZ | 989 |
AMAZON | 989 |
MICROSOFT | 978 |